Pioglitazone (Pio) is a thiazolidinedione (TZD) insulin-sensitizing drug whose outcomes end final result predominantly from its modulation of the transcriptional practice of peroxisome proliferator-activated-receptor-gamma (PPARγ). Pio is used to
Pioglitazone (Pio) is a thiazolidinedione (TZD) insulin-sensitizing drug whose outcomes end final result predominantly from its modulation of the transcriptional practice of peroxisome proliferator-activated-receptor-gamma (PPARγ). Pio is used to